188 related articles for article (PubMed ID: 23939625)
1. Clonal selection and persistence in dysplastic Barrett's esophagus and intramucosal cancers after failed radiofrequency ablation.
Zeki SS; Haidry R; Graham TA; Rodriguez-Justo M; Novelli M; Hoare J; Dunn J; Wright NA; Lovat LB; McDonald SA
Am J Gastroenterol; 2013 Oct; 108(10):1584-92. PubMed ID: 23939625
[TBL] [Abstract][Full Text] [Related]
2. Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy.
Odze RD; Lauwers GY
Endoscopy; 2008 Dec; 40(12):1008-15. PubMed ID: 19065484
[TBL] [Abstract][Full Text] [Related]
3. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic therapy using radiofrequency ablation for esophageal dysplasia and carcinoma in Barrett's esophagus.
van Vilsteren FG; Bergman JJ
Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):55-74, vi. PubMed ID: 19951794
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation for Barrett's-associated intramucosal carcinoma: a multi-center follow-up study.
Strauss AC; Agoston AT; Dulai PS; Srivastava A; Rothstein RI
Surg Endosc; 2014 Dec; 28(12):3366-72. PubMed ID: 24950726
[TBL] [Abstract][Full Text] [Related]
6. Pseudo-buried Barrett's post radiofrequency ablation for Barrett's esophagus, with or without prior endoscopic resection.
Pouw RE; Visser M; Odze RD; Sondermeijer CM; ten Kate FJ; Weusten BL; Bergman JJ
Endoscopy; 2014 Feb; 46(2):105-9. PubMed ID: 24285123
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
[TBL] [Abstract][Full Text] [Related]
8. Esophageal motility and impedance characteristics in patients with Barrett's esophagus before and after radiofrequency ablation.
Hemmink GJ; Alvarez Herrero L; Bogte A; Bredenoord AJ; Bergman JJ; Smout AJ; Weusten BL
Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1024-32. PubMed ID: 23708277
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry.
Haidry RJ; Dunn JM; Butt MA; Burnell MG; Gupta A; Green S; Miah H; Smart HL; Bhandari P; Smith LA; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Novelli M; Banks MR; Lovat LB
Gastroenterology; 2013 Jul; 145(1):87-95. PubMed ID: 23542069
[TBL] [Abstract][Full Text] [Related]
10. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium.
Gupta M; Iyer PG; Lutzke L; Gorospe EC; Abrams JA; Falk GW; Ginsberg GG; Rustgi AK; Lightdale CJ; Wang TC; Fudman DI; Poneros JM; Wang KK
Gastroenterology; 2013 Jul; 145(1):79-86.e1. PubMed ID: 23499759
[TBL] [Abstract][Full Text] [Related]
13. Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients.
Lee RG
Am J Surg Pathol; 1985 Dec; 9(12):845-52. PubMed ID: 2416226
[TBL] [Abstract][Full Text] [Related]
14. Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett's esophagus.
Lee JK; Cameron RG; Binmoeller KF; Shah JN; Shergill A; Garcia-Kennedy R; Bhat YM
Endoscopy; 2013 Jul; 45(7):571-4. PubMed ID: 23592390
[TBL] [Abstract][Full Text] [Related]
15. Detection of buried Barrett's glands after radiofrequency ablation with volumetric laser endomicroscopy.
Swager AF; Boerwinkel DF; de Bruin DM; Faber DJ; van Leeuwen TG; Weusten BL; Meijer SL; Bergman JJ; Curvers WL
Gastrointest Endosc; 2016 Jan; 83(1):80-8. PubMed ID: 26124075
[TBL] [Abstract][Full Text] [Related]
16. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
[TBL] [Abstract][Full Text] [Related]
18. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.
Shaheen NJ; Overholt BF; Sampliner RE; Wolfsen HC; Wang KK; Fleischer DE; Sharma VK; Eisen GM; Fennerty MB; Hunter JG; Bronner MP; Goldblum JR; Bennett AE; Mashimo H; Rothstein RI; Gordon SR; Edmundowicz SA; Madanick RD; Peery AF; Muthusamy VR; Chang KJ; Kimmey MB; Spechler SJ; Siddiqui AA; Souza RF; Infantolino A; Dumot JA; Falk GW; Galanko JA; Jobe BA; Hawes RH; Hoffman BJ; Sharma P; Chak A; Lightdale CJ
Gastroenterology; 2011 Aug; 141(2):460-8. PubMed ID: 21679712
[TBL] [Abstract][Full Text] [Related]
19. Management of Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma.
Cotton CC; Eluri S; Shaheen NJ
Gastroenterol Clin North Am; 2022 Sep; 51(3):485-500. PubMed ID: 36153106
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of invasive cancer after endoscopic treatment of Barrett's esophagus with high-grade dysplasia and intramucosal cancer in physiologically fit patients: time for a review of surveillance and treatment guidelines.
Templeton A; Bodnar A; Gan SI; Irani S; Ross A; Low D
Gastrointest Endosc; 2014 May; 79(5):839-44. PubMed ID: 24447341
[No Abstract] [Full Text] [Related]
[Next] [New Search]
